🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Have you got questions about #MultipleSclerosis research? Join our co-founder & chief science communicator, Brett Drummond, on Facebook Live to ask them. He’s broadcasting NOW & would love you to join the conversation! #MS fb.watch/ytDdwMxPHY/

VOTE NOW: I value reading about the personal journeys and experiences of other people living with #MultipleSclerosis, as much as I benefit from hearing about developments in #MS research and understanding…

Claire Robertson (University of Aberdeen) is studying if comics can be effective in improving understanding of invisible symptoms in #MultipleSclerosis. We support any efforts to improve awareness in this area & wish Claire the best. Thanks MSTrust for sharing! mstrust.org.uk/news/stories/m…

What role can #diet play in the management of #MultipleSclerosis? What does the latest research tell us about different diets & their impacts? This is all discussed in the latest episode of The ECTRIMS Podcast, feat. Dr Brigit de Jong from MS Centrum Amsterdam. ectrims.eu/podcast/episod…

What do the tolebrutinib trial results mean for people living with #MultipleSclerosis? What’s the latest update on the metformin & clemastine remyelination clinical trial? These topics & a special announcement are included in our latest website article. mstranslate.com.au/multiple-scler…

Researchers have long explored the connection between the gut microbiome & #MultipleSclerosis. Now, University of Iowa research suggests specific gut bacteria could help predict disease severity in people with #MS. Another promising step towards personalised care. gutmicrobiotaforhealth.com/a-new-stool-bi…

Our co-founder, Brett Drummond, is on #FacebookLive NOW discussing all things related to #MultipleSclerosis research. Join him, ask your questions and be part of the conversation. Everyone is welcome! #MS fb.watch/zGFuqcWzNs/

The #MultipleSclerosis Research Flagship at Menzies Research has released a new online course ahead of #WorldMSDay. This free module connects to the 2025 campaign, providing info on the diagnosis, symptoms & challenges of living with #MS. MS Int'l Federation ms.mooc.utas.edu.au/course/20344

Heard of the central vein sign (CVS) in #MultipleSclerosis? It’s a proposed biomarker, appearing on MRI, that can help with the diagnosis of #MS. While there’s more to learn, Uni of Nottingham #WeAreUoN research has suggested the CVS might be as effective as a lumbar puncture for diagnosis.

A new University of Auckland | Waipapa Taumata Rau study has found that the rates of #MultipleSclerosis are on the rise in New Zealand. Importantly, they found this was the case across a range of ethnic backgrounds, incl. European New Zealanders, Māori, Pacific peoples & Asian groups. auckland.ac.nz/en/news/2025/0…

Phase 3 trials of Roche's Bruton's tyrosine kinase inhibitor (BTKi), fenebrutinib, are currently underway. However, long-term follow-up of participants from the Phase 2 trial are showing some promising results. #MultipleSclerosis #MS roche.com/media/releases…

"It is a significant finding to see this accelerated aging in children. If we can understand the interplay between the immune system, the brain and aging…we might be able to put #MS into full remission" - Dr Jennifer Graves, UC San Diego #MultipleSclerosis today.ucsd.edu/story/uc-san-d…